National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 24810 [2018-11559]
Download as PDF
<![CDATA[
24810
Federal Register / Vol. 83, No. 104 / Wednesday, May 30, 2018 / Notices
Dated: May 24, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–11561 Filed 5–29–18; 8:45 am]
BILLING CODE 4140–01–P
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 23, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–11559 Filed 5–29–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of Microbiology, Infectious
Diseases and AIDS Initial Review Group
Microbiology and Infectious Diseases B
Subcommittee MID–B.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group Microbiology and Infectious Diseases
B Subcommittee MID–B.
Date: June 18–19, 2018.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Ellen S. Buczko, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, 301–451–2676, ebuczko1@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Project: 2019 National Survey on Drug
Use and Health
(OMB No. 0930–0110)—Revision
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, June
26, 2018, 11:00 a.m. to June 26, 2018,
2:00 p.m., National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 which
was published in the Federal Register
on May 11, 2018, 83 FR 22091.
This meeting notice is amended to
change the time of the meeting from
11:00 a.m.–2:00 p.m. to 10:00 a.m.–1:00
p.m. The meeting is closed to the
public.
Dated: May 23, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–11489 Filed 5–29–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for Office of
Management and Budget (OMB)
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
The National Survey on Drug Use and
Health (NSDUH) is a survey of the U.S.
civilian, non-institutionalized
population aged 12 years old or older.
The data are used to determine the
prevalence of use of tobacco products,
alcohol, illicit substances, and illicit use
of prescription drugs. The results are
used by SAMHSA, the Office of
National Drug Control Policy (ONDCP),
federal government agencies, and other
organizations and researchers to
establish policy, to direct program
activities, and to better allocate
resources.
While NSDUH must be updated
periodically to reflect changing
substance use and mental health issues
and to continue producing current data,
only the following minor changes are
planned for the 2019 NSDUH: (1)
Adding a brief series of questions on
medication-assisted treatment (MAT) for
opioids and alcohol; and, (2) including
other minor wording changes to
improve the flow of the interview, to
increase respondent comprehension, or
to be consistent with text in other
questions.
The series of MAT questions seeks to
identify medications prescribed by
health professionals to help reduce or
stop the use of opioids and alcohol.
Including these questions in NSDUH
will allow SAMHSA to provide the first
known national-level estimates on the
use of MAT for opioid use disorder and
alcohol use disorder.
As with all NSDUH surveys
conducted since 1999, including those
prior to 2002 when the NSDUH was
referred to as the National Household
Survey on Drug Abuse, the sample size
of the survey for 2019 will be sufficient
to permit prevalence estimates for each
of the 50 states and the District of
Columbia. The total annual burden
estimate is shown below in Table 1:
sradovich on DSK3GMQ082PROD with NOTICES
TABLE 1—ANNUALIZED ESTIMATED BURDEN FOR 2019 NSDUH
Number of
respondents
Instrument
Household Screening ...........................................................
Interview ...............................................................................
Screening Verification ..........................................................
Interview Verification ............................................................
VerDate Sep<11>2014
17:04 May 29, 2018
Jkt 244001
PO 00000
Frm 00094
Responses
per
respondent
137,231
67,507
4,116
10,126
Fmt 4703
Sfmt 4703
Total number
of responses
1
1
1
1
137,231
67,507
4,116
10,126
E:\FR\FM\30MYN1.SGM
30MYN1
Hours per
response
0.083
1.000
0.067
0.067
Total burden
hours
11,390
67,507
276
678
]]>Agencies
[Federal Register Volume 83, Number 104 (Wednesday, May 30, 2018)]
[Notices]
[Page 24810]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-11559]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of Microbiology,
Infectious Diseases and AIDS Initial Review Group Microbiology and
Infectious Diseases B Subcommittee MID-B.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Microbiology, Infectious Diseases and AIDS
Initial Review Group Microbiology and Infectious Diseases B
Subcommittee MID-B.
Date: June 18-19, 2018.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Ellen S. Buczko, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health/NIAID, 6700B Rockledge
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-451-2676,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: May 23, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-11559 Filed 5-29-18; 8:45 am]
BILLING CODE 4140-01-P
